Drawing for AVETECH

USPTO serial 87605004

AVETECH

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
ROACH, APRIL K
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AVETECH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Timothy T. Wang

TIMOTHY T. WANG NI, WANG & MASSAND, PLLC8140 WALNUT HILL LN., STE. 500DALLAS, TX 75231UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Biochemical catalysts; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical reagents, other than for medical or veterinary purposes; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; Cryogenic preparations in solid, liquid or gas state for use in chilling and freezing; diagnostic preparations, other than for medical or veterinary purposes; reagent paper, other than for medical or veterinary purposes; test paper, chemicalACTIVE—
005Chemical preparations for the diagnosis of pregnancy; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; preparations, namely, cultures, of microorganisms for medical and veterinary use; pharmaceutical preparations for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; enzyme preparations for medical purposes; siccatives for medical purposes; Medicated lotions for skin and body; reagent paper for medical purposesACTIVE—
009Hydrometers; microtomes; incubators for bacteria culture; graduated glassware; microscopes; optical lenses; optical condensers ; microscopes and their parts; medical apparatus and instruments for use in the detection and analysis of body fluid, blood, urine, feces, and sample sections of human and animal tissue, for medical research use; medical analytical apparatus for use in the analysis of body fluid, blood, urine, feces, and sample sections of human and animal tissue, for medical research use; medical testing apparatus for use in the analysis of body fluid, blood, urine, feces, and sample sections of human and animal tissue, for medical research useACTIVE—
010Blood testing apparatus; hematimeters; Urethral probes; Urethral syringes; medical apparatus and instruments for use in the detection and analysis of body fluid, blood, urine, feces, and sample sections of human and animal tissue, for medical diagnostic use; medical analytical apparatus for use in the analysis of body fluid, blood, urine, feces, and sample sections of human and animal tissue, for medical diagnostic use; medical testing apparatus for use in the analysis of body fluid, blood, urine, feces, and sample sections of human and animal tissue, for medical diagnostic use; Medical diagnostic apparatus for use in the analysis of body fluid, blood, urine, feces, and sample sections of human and animal tissue; X-ray apparatus for medical purposes; electrocardiographs; direct current therapeutic apparatus; direct current medicine-inductiveness therapeutic apparatus; low frequency pulse therapeutic apparatus; intermediate frequency pulse therapeutic apparatus; high frequency pulse therapeutic apparatus; static therapeutic apparatus; radiological apparatus for medical purposes; radiotherapy apparatus; X-ray tubes for medical purposes; Patient x-ray radiation shields; magnetic field therapy apparatus; Ultrasonic therapy machines and apparatus; constant speed therapy apparatus; electric acupuncture instruments; collection kit consisting of glass and test tubes for collecting body fluid, blood, urine, feces; Medicinal catheters; furniture especially made for medical purposesACTIVE—
035Retail and wholesale services, namely, online retail and wholesale stores, featuring medical supplies and medical preparations for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Retail drug store services; wholesale drug service, namely, wholesale distributorships featuring pharmaceutical drugs; Health preparation retail and wholesale services, namely, wholesale and retail store services in the field of pharmaceutical preparations for enhancing health; veterinary drugs retail and wholesale services, namely, online retail and wholesale distributorships featuring veterinary drugsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 31, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 30, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 26, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 31, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 31, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 11, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 26, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 22, 2021RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Sep 23, 2020RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Feb 24, 2020RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Aug 19, 2019RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Feb 15, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 15, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Feb 15, 2019CNSLSUSPENSION LETTER WRITTEN—
Jan 29, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 28, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 28, 2019ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jan 9, 2019ATRVATTORNEY REVIEW COMPLETED—
Jan 7, 2019AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Jan 7, 2019ALIEASSIGNED TO LIE—
Jan 3, 2019GNS1NOTIFICATION OF SUBSEQUENT FINAL EMAILED—
Jan 3, 2019GNCFCONTINUATION OF FINAL REFUSAL E-MAILED—
Jan 3, 2019CNCFACTION CONTINUING A FINAL - COMPLETED—
Jan 2, 2019PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Dec 28, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 27, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 27, 2018ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jun 27, 2018GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jun 27, 2018GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 27, 2018CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 19, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 18, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 18, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 18, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 18, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 18, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 15, 2017DOCKASSIGNED TO EXAMINER—
Sep 19, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Sep 16, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 15, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance